Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abiraterone acetate food-effect study in mCRPC
NCT02730975Phase 1Completed
- Sponsor
- Fundación Pública Andaluza para la Gestión de la Investigación
- Start
- May 2014
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of abiraterone in metastatic castration-resistant prostate cancer (mCRPC), sponsored by Fundación Pública Andaluza para la Gestión de la Investigación. Started May 2014; status: completed.
02
Drugs
abiraterone
03
Conditions
metastatic castration-resistant prostate cancer (mCRPC)
Beyond the preview
Go deeper on NCT02730975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02730975.